+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 54Years
FEMALE
ID05116930

Pilot Study of Neostigmine and Glycopyrrolate IV Treatment for Post-Dural Puncture Headache in Postpartum Women After Epidural Tuohy Needle Puncture

Led by Mayo Clinic · Updated on 2026-03-23

18

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of Neostigmine and Glycopyrrolate to treat post-dural puncture headache PDPH in postpartum women who develop this headache after an accidental dural puncture with a Tuohy needle. The study aims to reduce the number of women with PDPH who need an epidural blood patch EBP, which is the current standard treatment but carries some risks and contraindications. This pilot study builds on earlier findings that suggested these drugs might help reduce headache severity and EBP need. In this study, women with PDPH and a pain score of 4 or higher will receive intravenous infusions of Neostigmine 20 mcgkg and Glycopyrrolate 4 mcgkg over 10 minutes. This treatment is given every 8 hours for up to three doses or until pain is reduced to a score of 3 or less. Alongside the study drugs, patients will also receive standard supportive treatments such as hydration, caffeine, acetaminophen, ibuprofen, and pain medication as needed. Participants are carefully monitored during and after infusions for vital signs and possible side effects like muscle cramps or blurred vision. Participants will be assessed daily in the hospital for headache symptoms, and pain scores will be tracked at multiple time points up to two weeks after treatment. Researchers will monitor the number of women requiring EBP within two weeks, changes in pain levels, and any adverse events. The study includes safety monitoring with frequent blood pressure checks, continuous heart and oxygen monitoring during infusions, and follow-up evaluations to understand treatment effects and safety. Participation continues until headache resolution or decision to receive EBP, with total follow-up lasting up to two weeks after intervention.

CONDITIONS

Brief Title

Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here